Eli Lilly and Company (LLY) vs UnitedHealth Group Incorporated (UNH)

See how Eli Lilly and Company and UnitedHealth Group Incorporated differ across market data and performance, so you can decide which asset best fits your strategy.

$1,266.06
NYSE
Eli Lilly & Co. is a pharmaceutical company focused on neuroscience, cardiometabolic disease, oncology, and immunology. Its leading products include Verzenio and Jaypirca in cancer treatment; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin in cardiometabolic care; and Taltz and Olumiant in immunology.
View Full Page
$399.92
NYSE
UnitedHealth Group Incorporated is among the world’s largest private health insurers, providing medical benefits to roughly 51 million members globally as of December 2025, including about 1 million outside the United States. A leading provider of employer-sponsored, self-directed, and government-supported health plans, the company has built substantial scale in the medical insurance market. In addition to its core insurance operations, UnitedHealth’s Optum businesses expand its reach across healthcare services, spanning pharmacy benefits, outpatient care, and analytics for affiliated organizations and third-party clients.
View Full Page

Key Metrics Comparison

Eli Lilly and CompanyLLY
Market Cap
$1.129T
Price
$1,266.06
24h Change
+1.15%
24h Volume
$400K
Employees
50,000
Shares Outstanding
944,818,881
UnitedHealth Group IncorporatedUNH
Market Cap
$358.966B
Price
$399.92
24h Change
-1.66%
24h Volume
$1.82M
Employees
390,000
Shares Outstanding
908,213,180

Category Performance

Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.

Market Share

Share of combined market cap

Market Share
LLY
75.9%
UNH
24.1%

Volume Share

Share of combined 24h volume

Volume Share
LLY
18.1%
UNH
81.9%

24h Performance

Price change over last 24 hours

24h Performance
LLY
1.15%
UNH
-1.66%
Price Comparison
Eli Lilly and Company
UnitedHealth Group Incorporated